Acta psychologica · 2026
Examining attention- deficit/ hyperactivity disorder in endurance and ultra-endurance runners.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Scheer Volker, Valero David, Valero Encarna, Weiss Katja, Rosemann Thomas, Knechtle Beat
Аннотация
BACKGROUND: Attention-deficit hyperactivity disorder (ADHD) is a multifactorial and complex neurodevelopmental disorder. Prevalence of ADHD in the general adult population is around 3.1 %, with little data available in athlete population suggesting rates of between 7 %-8 %. No data are available for endurance and ultra-endurance runners.
METHODS: Cross-sectional survey study in endurance (≥21.1 km to 42.2 km) and ultra-endurance runners (≥42.2 km), using the Adult Attention Deficit/Hyperactivity Disorder Self-Report Scale (ASRS-5) for screening for ADHD and assessing associated risk factors and sex differences using statistical and machine learning (ML) techniques.
RESULTS: A total of 601 runners participated (female n = 222; male n = 379; mean age 42.8 ± 10.1 years). Overall, 9.7 % of runners returned screening results above the cut off score from the ASRS-5 for ADHD, particularly half-marathon runners (14.8 %; n.s.) compared to marathon (8.0 %) and ultramarathon runners (8.7 %). No significant sex differences (female 10.8 % versus men 9.0 %) or differences in performance levels (elite (0.0 %) versus non-elite (10.1 %) runners) were observed. Age was the only statistically significant associated factor (p = 0.03), particularly in younger runners (under the age of 40 years).
CONCLUSION: This study provides novel essential screening data on ADHD among endurance and ultra-endurance runners. The screening rates for ADHD traits exceed those found in previous studies with elite athletes and the general population. Clinical evaluation, using standard clinical criteria to verify the responses for a definitive diagnosis of ADHD is recommended, as well as increasing awareness of ADHD, education, support services and targeted interventions. Sports organizations, health professionals, and policymakers should implement systematic screening and education programs to address these concerns.
METHODS: Cross-sectional survey study in endurance (≥21.1 km to 42.2 km) and ultra-endurance runners (≥42.2 km), using the Adult Attention Deficit/Hyperactivity Disorder Self-Report Scale (ASRS-5) for screening for ADHD and assessing associated risk factors and sex differences using statistical and machine learning (ML) techniques.
RESULTS: A total of 601 runners participated (female n = 222; male n = 379; mean age 42.8 ± 10.1 years). Overall, 9.7 % of runners returned screening results above the cut off score from the ASRS-5 for ADHD, particularly half-marathon runners (14.8 %; n.s.) compared to marathon (8.0 %) and ultramarathon runners (8.7 %). No significant sex differences (female 10.8 % versus men 9.0 %) or differences in performance levels (elite (0.0 %) versus non-elite (10.1 %) runners) were observed. Age was the only statistically significant associated factor (p = 0.03), particularly in younger runners (under the age of 40 years).
CONCLUSION: This study provides novel essential screening data on ADHD among endurance and ultra-endurance runners. The screening rates for ADHD traits exceed those found in previous studies with elite athletes and the general population. Clinical evaluation, using standard clinical criteria to verify the responses for a definitive diagnosis of ADHD is recommended, as well as increasing awareness of ADHD, education, support services and targeted interventions. Sports organizations, health professionals, and policymakers should implement systematic screening and education programs to address these concerns.